Physician profile
Peter J Grant
NPI 1306853858
$2,346.22
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $533 · 2021: $953 · 2022: $265 · 2023: $23.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $286.77 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $263.66 | 2019-2022 | |
| Medtronic, INC. | $235.83 | 2021 | |
| Abbvie INC. | $196.64 | 2019-2022 | |
| Pfizer INC. | $181.59 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $173.60 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $166.41 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $142.80 | 2020-2022 | |
| Lilly USA, LLC | $120.63 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $112.03 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $79.22 | 2019-2020 | |
| Genentech USA, INC. | $71.68 | 2019-2020 | |
| Sanofi Pasteur INC. | $66.23 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.50 | 2021-2022 | |
| Ethicon US, LLC | $25.30 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.16 | 2023 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.95 | 2020 | |
| Boston Scientific Corporation | $19.75 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.14 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $17.86 | 2021 | |
| Gilead Sciences, INC. | $17.41 | 2020 | |
| Ucb, INC. | $16.56 | 2020 | |
| Adlon Therapeutics L.P. | $14.97 | 2019 | |
| Circassia INC. | $14.66 | 2019 | |
| Allergan, INC. | $13.69 | 2020 | |
| Shire North American Group INC | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.